The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | Pathology practice, an ever-changing field as more biomarkers emerge
Lung cancer treatment has changed drastically in recent years, and along with it the role of the pathologist. We spoke to Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen, Aberdeen, UK, about this at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland. Prof. Kerr highlights the increasing number of biomarkers, and the changing complexities and variety of pathology practice as a result.
